Abstract
Objectives
Studies have consistently shown a lower cardiovascular risk in women who received postmenopausal hormone replacement therapy (HRT).
Design and Methods
In this study, the effects of HRT were investigated on plasma total homocysteine (tHcy) and the oxidant-antioxidant status in postmenopausal women. 35 of postmenopausal receiving (2 mg estrodiol valerate + 1 mg cyproterone acetate) HRT group, the remaining 25 received orally placebo (NHRT group).
Results
There was no significant change in plasma tHcy levels between HRT and NHRT groups. Malondialdehyde (MDA) and total thiol (t-SH) correlated significantly with tHcy (0.388 and 0.478, respectively) content, and there was a significant negative correlation between E2 level and glutathione transferase (GST) activity (−0.425) in HRT group. Superoxide dismutase (SOD) and HDL-C correlated significantly with t-SH level (0.339 and 0.336, respectively) in plasma after HRT.
Conclusion
Our results show that HRT is beneficial in the protection against oxidative damage, and prevents atherosclerotic complications.
Similar content being viewed by others
References
Marchesoni D, Driul L, Plaino L, Villani MT, Becagli L, Mozanega B (2003) Menopause rather than estrogen modifies plasma homocysteine levels. Int J Gynecol Obstet 81:293–297
Jung K, Kim S, Jeongik W, Chang Y (2002) The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TxB2 level Korean postmenopausal women with hypercholesterolemia. J Korean Med Sci 17:307–315
Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ (1999) Effects of menopause and hormone replacement therapy on plasma lipids, lipoprteins and LDL-receptor activity. Maturitas 33:259–269
Kannel WB, Hjortland MC, Mc Namara PM, Gordon T (1976) Menopause and risk of cardio-vascular disease: the Framingham study. Ann Intern Med 85:447–452
Peters HWW, Westendorp ICD, Hak AE, Grobbee DE, Stehouwer CDA, Hofman A et al (1999) Menopausal status and risk factors for cardiovascular disease. J Intern Med 246:521–528
Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J et al (2007) WHI and WHI-CACS investigators. Estrogen therapy and coronary–artery calcification. N Engl J Med 297:1465–1477
Bar J, Tepper R, Fucs J, Pardo Y, Goldberger S, Ovadia J (1993) The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 81:261–264
Rosano GMC, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M et al (2009) Hormone replacement therapy and cardioprotection: a new dawn? A statement of the study group on cardiovascular disease in women of the Italian Society of cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med 10:85–92
Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM et al (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465–1477
Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J et al (2007) WHI and WHI-CACS investigators. Estrogen therapy and coronary–artery calcification. N Engl J Med 356:2591–2602
Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C et al (2001) Oxidative stress and homocysteine in coronary artery disease. Clin Chem 47:887–892
Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308–318
Mijatovic V, van der Mooren MJ (2001) Homocysteine in postmenopausal women and the importance of hormone replacement therapy. Clin Chem Lab Med 39:764–767
Hak AE, Polderman KH, Westendorp IC, Iakobs C, Hofman A, Wıtteman IC et al (2000) Increased plasma homocysteine after menopause. Atherosclerosis. 149:163–168
Madsen JS, Kristensen SR, Klitgaard NA, Bladbjerg EM, Abrahamsen B, Stilgen L et al (2002) Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am J Obstet Gynecol 187:33–39
Bureau I, Laporte F, Favier M, Faure H, Fiels M, Favier AE et al (2002) No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr 21:333–338
Castelao JE, Gago-Dominquez M (2008) Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses 71:39–44
Gokkuşu C, Tata G, Ademoglu E, Tamer S (2010) The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women. Platelets 21:439–444
Leal M, Diaz J, Serrano E, Abellan J, Carbonell LF (2000) Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 95:804–809
Clemente C, Carusa MG, Berloco P, Notarnicola M, D’Attoma B, Osella AR et al (1999) Antioxidant effect of short-term hormonal treatment in postmenopausal women. Maturitas 31:137–142
Mittal PC, Kant R (2009) Correlation of increased oxidative stress to body weight in disease-free postmenopausal women. Clin Biochem 42:1007–1011
Jha R, Rizvi SI (2011) Carbonyl formation in erythrocyte membrane proteins during aging in humans. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155:39–42
Bagatini MD, Martins CC, Battisti V, Gasparetto D, da Rosa CS, Spanevello RM et al (2011) Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels 26:55–63
Oh JM, Kim SH, Suh CH, Nahm DH, Park HS, Lee YM et al (2005) Lack of association of glutathione S-transferase P1Ile105Val polymorphism with aspirin-intolerant asthma. Korean J Int Med 20:232–236
Darabi M, Ani M, Movahedian A, Zarean E, Panjehpour M, Rabbani M (2010) Effect of hormone replacement therapy on total serum anti-oxidant potential and oxidized LDL/ß2-glycoprotein I complexes in postmenopausal women. Endocr J 57:1029–1034
Leino A (1999) Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMX analyzer. Clin Chem 91:308–318
Wasowicz W, Neve J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substance in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522–2526
Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:359–363
Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Method Enzymol 233:380–385
Sun Y, Oberley LW (1994) Suitability of cooper chloride as a reaction terminator superoxide dismutase activity assay. Clin Chim Acta 226:101–103
Habig WH, Jakoby WB (1981) Assay for differentiation of glutathione S-transferases. Method Enzymol 77:398–405
Smolders RGV, van der Mooren MJ, Teerlink T, Merkus JMWM, Kroeks MVAM, Franke HR et al (2003) A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril 79:261–267
Nielsen NE, Brattström L, Hultberg B, Landgren F, Swahn E (2000) Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease. Atherosclerosis 151:423–431
Christodoulakos G, Panoulis C, Rizos D, Moustakarias T, Phocas I, Creatsas G (2001) Homocysteine and folate levels in postmenopausal women. Maturitas 39:161–167
De la Calle M, Usandizaga R, Sancha M, Magdaleno F, Herranz A, Cabrillo E (2003) Homocysteine, folic acid and B-group vitamins in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 107:125–134
Farag NH, Barshop BA, Mills PJ (2003) Effects of estrogen and psychological stress on plasma homocysteine levels. Fertil Steril 7:256–260
Mutlu-Turkoglu U, Ilhan E, Oztezcan S, Kuru A, Aykac-Toker G, Uysal M (2003) Age-related increase in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 36:397–400
Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G et al (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53:77–82
Bednarek-Tupikowska G, Tupikowski K, Bidzinska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B et al (2004) Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 19:57–63
Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bidzinska B, Milewicz A, Antonowicz-Juchniewicz J, Andrzejak R (2001) Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and, postmenopausal women. Gynecol Endocrinol 15:298–303
Genc S, Gurdol F, Oner-Iyidogan Y, Suzme R (1999) Acute effects of estradiol and of DES: Pro- or antioxidant potency? Res Commun Molec Pathol Pharmacol 105:253–261
Ruiz-Larrea MB, Garrido J, Locart M (1993) Estradiol-induced effects on glutathione metabolism in rat hepatocytes. J Biochem 113:563–567
Knapen MFCM, Zusterzeel PLM, Peters WHM, Steegers EAP (1999) Glutathione and glutathione-related enzymes in reproduction. Eur J Obstet Gyn RB 82:171–184
Mulder TPJ, Knapen FCM, Van der Mooren MJ, Demacker PD, Roes EM, Steegers EAP et al (1998) Effects of hormone replacement therapy on plasma glutathione s-transferase α1–1 concentrations in healthy postmenopausal women. Clin Chem 44:666–667
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gökkuşu, C., Özbek, Z. & Tata, G. Hormone replacement therapy: relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women. Arch Gynecol Obstet 285, 733–739 (2012). https://doi.org/10.1007/s00404-011-2051-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-011-2051-2